Truncated forms of the androgen receptor are associated with polyglutamine expansion in X-linked spinal and bulbar muscular atrophy
- PMID: 9384612
- DOI: 10.1093/hmg/7.1.121
Truncated forms of the androgen receptor are associated with polyglutamine expansion in X-linked spinal and bulbar muscular atrophy
Abstract
X-linked spinal and bulbar muscular atrophy (SBMA) is a rare form of motor neuron degeneration linked to a CAG repeat expansion in the first exon of the androgen receptor gene coding for a polyglutamine tract. In order to investigate the properties of the SBMA androgen receptor in neuronal cells, cDNAs coding for a wild-type (19 CAG repeats) and a SBMA mutant androgen receptor (52 CAG repeats) were transfected into mouse neuroblastoma NB2a/d1 cells. The full length androgen receptor proteins, of 110-112 kDa and 114-116 kDa for the wild-type and mutant protein, respectively, were detected by Western blotting in transfected cells. In addition, the presence of an expanded polyglutamine tract in the SBMA androgen receptor appears to enhance the production of C-terminally truncated fragments of the protein. A 74 kDa fragment was particularly prominent in cells expressing the SBMA androgen receptor. From its size, it can be deduced that the 74 kDa fragment lacks the hormone binding domain but retains the DNA binding domain. The 74 kDa fragment may therefore be toxic to motor neurons by initiating the transcription of specific genes in the absence of hormonal control. Immunofluorescence microscopy on transfected NB2a/d1 cells showed that, after hormone activation, the wild-type androgen receptor translocated to the nucleus whereas the SBMA androgen receptor was mainly localized in the cytoplasm in the form of dense aggregates with very little androgen receptor protein in the nucleus. This could explain the reduction in transcriptional activity of the SBMA mutant as compared with wild-type androgen receptor.
Similar articles
-
Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy.Hum Mol Genet. 2006 Jul 15;15(14):2225-38. doi: 10.1093/hmg/ddl148. Epub 2006 Jun 13. Hum Mol Genet. 2006. PMID: 16772330
-
Transcriptional activation by the androgen receptor in X-linked spinal and bulbar muscular atrophy.J Neurol Sci. 1996 Oct;142(1-2):12-6. doi: 10.1016/0022-510x(96)00142-6. J Neurol Sci. 1996. PMID: 8902713
-
[Triplet repeat disease, with particular emphasis of spinal and bulbar muscular atrophy (SBMA)].Rinsho Shinkeigaku. 2000 Dec;40(12):1193-5. Rinsho Shinkeigaku. 2000. PMID: 11464455 Japanese.
-
Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA).Prog Neurobiol. 2012 Dec;99(3):246-56. doi: 10.1016/j.pneurobio.2012.05.007. Epub 2012 May 15. Prog Neurobiol. 2012. PMID: 22609045 Review.
-
Spinal and bulbar muscular atrophy.Handb Clin Neurol. 2018;148:625-632. doi: 10.1016/B978-0-444-64076-5.00040-5. Handb Clin Neurol. 2018. PMID: 29478604 Review.
Cited by
-
Increased T-type Ca2+ channel activity as a determinant of cellular toxicity in neuronal cell lines expressing polyglutamine-expanded human androgen receptors.Mol Cell Biochem. 2000 Jan;203(1-2):23-31. doi: 10.1023/a:1007010020228. Mol Cell Biochem. 2000. PMID: 10724329
-
Chaperones in Polyglutamine Aggregation: Beyond the Q-Stretch.Front Neurosci. 2017 Mar 23;11:145. doi: 10.3389/fnins.2017.00145. eCollection 2017. Front Neurosci. 2017. PMID: 28386214 Free PMC article. Review.
-
Properties of polyglutamine expansion in vitro and in a cellular model for Huntington's disease.Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1013-9. doi: 10.1098/rstb.1999.0453. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434300 Free PMC article. Review.
-
Calpain-mediated proteolysis as driver and modulator of polyglutamine toxicity.Front Mol Neurosci. 2022 Oct 19;15:1020104. doi: 10.3389/fnmol.2022.1020104. eCollection 2022. Front Mol Neurosci. 2022. PMID: 36385755 Free PMC article. Review.
-
The early cellular pathology of Huntington's disease.Mol Neurobiol. 1999 Oct-Dec;20(2-3):111-24. doi: 10.1007/BF02742437. Mol Neurobiol. 1999. PMID: 10966117 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical